Reported covered position: Sen. Kelly
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2026 · first_quarter · Q1
Right2 To FDA Approved Products legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2025 · fourth_quarter · Q4
Source: Senate LDA
Right To FDA Approved Products legislation
Filing targets: SENATE
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2025 · third_quarter · Q3
Right To FDA Approved Products legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE